AFFiRiS Competitors and Similar CompaniesClear all
Bellerophon Therapeutics's competitors and similar companies include Entrada Therapeutics.
 Bellerophon Therapeutics Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. |  Entrada Therapeutics Entrada Therapeutics is a biopharmaceutical company focusing on intracellular biologics. | |
Founding Date | Founding Date 2009 | Founding Date 2016 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Warren, US HQ | Locations Boston, US HQ |
Employees | Employees 1715% decrease | Employees 18315% increase |
Valuation ($) | Valuation ($) 440.4 k | Valuation ($) 642.8 m |
Financial | ||
Net income | Net income ($19.8m) (FY, 2022) | Net income ($143.8m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 80m | Total funding raised $ 175.6m |
For sources of this data, please see the company profile
View Company Profiles
Entrada Therapeutics
HQ
Boston, US
Employees
183↑ 15% increase
Entrada Therapeutics is a biopharmaceutical company focusing on intracellular biologics.
View company